Market Research Logo

XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review

Section 1 - About the Company 5
XOMA Corp - Key Facts 5
XOMA Corp - Key Employees 6
XOMA Corp - Key Employee Biographies 7
XOMA Corp - Major Products and Services 8
XOMA Corp - History 9
XOMA Corp - Company Statement 13
XOMA Corp - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 16
XOMA Corp - Business Description 16
XOMA Corp - Corporate Strategy 17
XOMA Corp - SWOT Analysis 18
SWOT Analysis - Overview 18
XOMA Corp - Strengths 18
XOMA Corp - Weaknesses 19
XOMA Corp - Opportunities 20
XOMA Corp - Threats 21
XOMA Corp - Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30
XOMA Corp, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
May 18, 2017: XOMA Earns $10 Million Milestone Payment as Another of its Licensed Assets Advances into Clinical Development 32
May 09, 2017: XOMA Reports First Quarter 2017 Financial Results 33
Mar 16, 2017: XOMA Reports Fourth Quarter and Full Year 2016 Financial Results 34
Feb 16, 2017: XOMA Appoints Matthew Perry to its Board of Directors 36
Nov 09, 2016: XOMA Reports Third Quarter 2016 Achievements and Financial Results 37
Aug 03, 2016: XOMA Reports Second Quarter 2016 Achievements and Financial Results 39
May 04, 2016: XOMA Reports First Quarter 2016 Operational Achievements and Financial Results 41
Mar 09, 2016: XOMA Reports Fourth Quarter and Full-Year 2015 Financial Results 43
Section 6 – Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Tables
XOMA Corp, Key Facts 5
XOMA Corp, Key Employees 6
XOMA Corp, Key Employee Biographies 7
XOMA Corp, Major Products and Services 8
XOMA Corp, History 9
XOMA Corp, Subsidiaries 15
XOMA Corp, Key Competitors 22
XOMA Corp, Ratios based on current share price 23
XOMA Corp, Annual Ratios 24
XOMA Corp, Annual Ratios (Cont...1) 25
XOMA Corp, Interim Ratios 27
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30
XOMA Corp, Recent Deals Summary 31
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48
List of Figuress
XOMA Corp, Performance Chart (2012 - 2016)
XOMA Corp, Ratio Charts
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
XOMA Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

XOMA Corp (Xoma), formerly Xoma Ltd, is a biopharmaceutical company that discovers, develops antibody-based therapeutics. Its lead product, gevokizumab is a monoclonal antibody used for the treatment of a wide variety of inflammatory diseases and other diseases. Its other pipeline products include X358, X213 and X129. XOMA X358 is a human negative allosteric modulating insulin receptor antibody; X213 (formerly LFA 102) is an allosteric inhibitor of prolactin action; X129 is a potent fragment of a monoclonal antibody with negative allosteric modulation activity. Xoma has developed its proprietary antibody discovery, optimization and development technologies, comprising ADAPT, ModulX and OptimX. It operates through its subsidiaries in Bermuda, Ireland, and the US. Xoma is headquartered in Berkeley, California, the US.

XOMA Corp Key Recent Developments

May 18,2017: XOMA Earns $10 Million Milestone Payment as Another of its Licensed Assets Advances into Clinical Development
May 09,2017: XOMA Reports First Quarter 2017 Financial Results
Mar 16,2017: XOMA Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 16,2017: XOMA Appoints Matthew Perry to its Board of Directors
Nov 09,2016: XOMA Reports Third Quarter 2016 Achievements and Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;